Mylan Pharmaceuticals announced the voluntary recall of one lot of alprazolam 0.5mg tablets to the consumer/user level due to the potential presence of a foreign substance.
The recalled lot, Alprazolam Tablets 0.5mg; NDC 00378-4003-05 (500 tabs); Lot Number 8082708; Exp date 9/2020, was distributed between July 2019 and August 2019. Alprazolam, a benzodiazepine, is indicated for the treatment of panic disorder and for the management of anxiety disorders.
According to Mylan, patients may have a remote risk of infection if exposed to the foreign substance. The Company has notified its distributors, retailers, and consumers by letter about the proper handling of all recalled products.
At this time, the Company has not received any reports of adverse events related to this recall. Adverse reactions may be reported to the FDA’s MedWatch program.
For more information regarding this recall contact Mylan Pharmaceuticals, by calling (800) 796-9526 or emailing [email protected].
This article originally appeared on MPR